-
Metabolic rewiring in cancer: Targeting metabolic vulnerability for therapy
Khurshed, M., 2024, 245 p.Research output: PhD thesis › Thesis, fully internal
-
Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells
Khurshed, M., Prades-Sagarra, E., Saleh, S., Sminia, P., Wilmink, J. W., Molenaar, R. J., Crezee, H. & van Noorden, C. J. F., 1 Dec 2022, In: Cancers. 14, 24, 6228.Research output: Contribution to journal › Article* › Academic › peer-review
-
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)
Stroes, C. I., Schokker, S., Khurshed, M., van der Woude, S. O., Mathôt, R. A. A., Slingerland, M., de Vos-Geelen, J., Zucchetti, M., Matteo, C., van Dijk, E., Ylstra, B., Thijssen, V., Derks, S., Godefa, T., Dijksterhuis, W., Breimer, G. E., van Delden, O. M., Verhoeven, R. H. A., Meijer, S. L. & Bijlsma, M. F. & 1 others, , 2022, In: Therapeutic advances in medical oncology. 14Research output: Contribution to journal › Article* › Academic › peer-review
- All publications